(Q40213262)

18 September 2017

1 reference

title

Worldwide clinical experience with auranofin (English)

1 reference

18 September 2017

Morris RW

1

1 reference

18 September 2017

Cole DS

2

1 reference

18 September 2017

Horton J

3

1 reference

18 September 2017

Heuer MA

4

1 reference

18 September 2017

Pietrusko RG

5

1 reference

18 September 2017

publication date

1 March 1984

1 reference

18 September 2017

published in

Clinical Rheumatology

1 reference

18 September 2017

volume

3 Suppl 1

1 reference

18 September 2017

page(s)

105-111

1 reference

Auranofin. New oral gold compound for treatment of rheumatoid arthritis

18 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03342628

A single-blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03342628

The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis

21 January 2018

1 reference

12 December 2020

Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.

1 reference

12 December 2020

Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalate

1 reference

12 December 2020

Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03342628

1 reference

18 September 2017

1 reference